Search research articles
Contact Us
Filters
Showing results (401-410 of 425) with videos related to
Page
of 43
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 9, 2017
Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analyses
Maya Kohli-Lynch, Neal J Russell, Anna C Seale, et al.
Lancet (London, England)
|
August 23, 2014
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial
Robert C Read, David Baxter, David R Chadwick, et al.
The Lancet. Infectious Diseases
|
January 22, 2021
Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1-4 cross-sectional survey results
Jenny M MacLennan, Charlene M C Rodrigues, Holly B Bratcher, et al.
Frontiers in Immunology
|
June 21, 2021
Invasive Group B Streptococcus Disease With Recurrence and in Multiples: Towards a Better Understanding of GBS Late-Onset Sepsis
Mirjam Freudenhammer, Konstantinos Karampatsas, Kirsty Le Doare, et al.
The Journal of Infection
|
June 18, 2023
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial
Eimear Kelly, Melanie Greenland, Philip C S de Whalley, et al.
Epidemiology and Infection
|
January 22, 2024
The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal insight
Olivia Bird, Eva P Galiza, David Neil Baxter, et al.
The Lancet. Infectious Diseases
|
June 22, 2023
Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial
Ivan T Lee, Catherine A Cosgrove, Patrick Moore, et al.
Lancet (London, England)
|
August 9, 2021
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
Xinxue Liu, Robert H Shaw, Arabella S V Stuart, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 15, 2022
Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme
Jeremy P Carr, Jenny M MacLennan, Emma Plested, et al.
The Lancet. Respiratory Medicine
|
June 11, 2022
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial
Robert H Shaw, Xinxue Liu, Arabella S V Stuart, et al.
Page
of 43
Search research articles
Search
Showing results (401-410 of 425) with videos related to
Sort By:
Page
of 43
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 9, 2017
Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analyses
Maya Kohli-Lynch, Neal J Russell, Anna C Seale, et al.
Lancet (London, England)
|
August 23, 2014
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial
Robert C Read, David Baxter, David R Chadwick, et al.
The Lancet. Infectious Diseases
|
January 22, 2021
Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1-4 cross-sectional survey results
Jenny M MacLennan, Charlene M C Rodrigues, Holly B Bratcher, et al.
Frontiers in Immunology
|
June 21, 2021
Invasive Group B Streptococcus Disease With Recurrence and in Multiples: Towards a Better Understanding of GBS Late-Onset Sepsis
Mirjam Freudenhammer, Konstantinos Karampatsas, Kirsty Le Doare, et al.
The Journal of Infection
|
June 18, 2023
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial
Eimear Kelly, Melanie Greenland, Philip C S de Whalley, et al.
Epidemiology and Infection
|
January 22, 2024
The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal insight
Olivia Bird, Eva P Galiza, David Neil Baxter, et al.
The Lancet. Infectious Diseases
|
June 22, 2023
Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial
Ivan T Lee, Catherine A Cosgrove, Patrick Moore, et al.
Lancet (London, England)
|
August 9, 2021
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
Xinxue Liu, Robert H Shaw, Arabella S V Stuart, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 15, 2022
Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme
Jeremy P Carr, Jenny M MacLennan, Emma Plested, et al.
The Lancet. Respiratory Medicine
|
June 11, 2022
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial
Robert H Shaw, Xinxue Liu, Arabella S V Stuart, et al.
Page
of 43